Capecitabine with weekly paclitaxel for advanced breast cancer: a phase I dose-finding trial. (Q45148160)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15539915%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

title

Capecitabine with weekly paclitaxel for advanced breast cancer: a phase I dose-finding trial (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15539915%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

main subject

phase I clinical trial

0 references

1 reference

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15539915%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Stefan Aebi

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15539915%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

author name string

Catrina Uhlmann

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15539915%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Natalie Rijken

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15539915%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Peter Brauchli

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15539915%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Walter Mingrone

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15539915%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Daniel Rauch

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15539915%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Bernhard C Pestalozzi

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15539915%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Christoph Rochlitz

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15539915%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Swiss Group for Clinical Cancer Research

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15539915%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Swiss Institute for Applied Cancer Research

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15539915%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

publication date

1 January 2004

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15539915%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15539915%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

volume

67

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15539915%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15539915%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

page(s)

117-122

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15539915%20AND%20SRC:MED&resulttype=core&format=json

Tamoxifen for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group

5 January 2020

cites work

1 reference

A phase I and pharmacokinetic study of the combination of capecitabine and docetaxel in patients with advanced solid tumours

21 January 2018

1 reference

Phase I, dose-finding study of capecitabine in combination with docetaxel and epirubicin as first-line chemotherapy for advanced breast cancer

21 January 2018

1 reference

Randomised, phase II trial comparing oral capecitabine (Xeloda) with paclitaxel in patients with metastatic/advanced breast cancer pretreated with anthracyclines.

21 January 2018

1 reference

Tumor selective delivery of 5-fluorouracil by capecitabine, a new oral fluoropyrimidine carbamate, in human cancer xenografts

21 January 2018

1 reference

Cytokines induce uridine phosphorylase in mouse colon 26 carcinoma cells and make the cells more susceptible to 5'-deoxy-5-fluorouridine.

21 January 2018

1 reference

Nail toxicity related to weekly taxanes: an important issue requiring a change in common toxicity criteria grading?

21 January 2018

1 reference

A phase I and pharmacologic study of capecitabine and paclitaxel in breast cancer patients

21 January 2018

1 reference

Superior survival with capecitabine plus docetaxel combination therapy in anthracycline-pretreated patients with advanced breast cancer: phase III trial results

21 January 2018

1 reference

Pharmacobiologically based scheduling of capecitabine and docetaxel results in antitumor activity in resistant human malignancies

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1159/000080997

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15539915%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

1 reference